A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of KP-001
Clinical trial NCT06619054 · COMPLETED
Trial details
- NCT number
- NCT06619054
- Sponsor
- Kaken Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-24
- Primary completion
- 2025-05-16
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.